Clopyralid

Clopyralid

SCHEMBL3215470

COc1ccccc1C(=O)NS(=O)(=O)c1ccc(C(=O)NC2CC2)cc1.O=C(O)c1nc(Cl)ccc1Cl

nearest known ligand 0.44

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 6/20 0.44
MEN1 O00255 5/20 0.44
KCNA3 P22001 1/20 0.43
FLT1 P17948 1/20 0.42
FLT4 P35916 1/20 0.42
KDR P35968 1/20 0.42
BCL2L1 Q07817 1/20 0.42
MCL1 Q07820 1/20 0.42
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
ALDH1A1 P00352 3/20 0.40
LMNA P02545 3/20 0.40
HPGD P15428 1/20 0.40
GPR119 Q8TDV5 1/20 0.40
ABCC3 O15438 1/20 0.40
ABCC4 O15439 1/20 0.40
ABCC9 O60706 1/20 0.40
ABCB11 O95342 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3655826 0.86 KCNA3 (0.52) KMT2AMEN1KCNA3FLT1FLT4
SCHEMBL120129 0.86 KCNA3 (0.52) KMT2AMEN1KCNA3FLT1FLT4
SCHEMBL29687002 0.86 KCNA3 (0.52) KMT2AMEN1KCNA3FLT1FLT4
3,6 Dichloromethoxybenzoic Acid SCHEMBL3224960 0.85 KCNA3 (0.44) KMT2AMEN1KCNA3FLT1FLT4
Picloram SCHEMBL3231524 0.85 KCNA3 (0.41) KMT2AMEN1KCNA3FLT1FLT4
Triclopyr SCHEMBL3219703 0.80 L3MBTL1 (0.42) KMT2AMEN1KCNA3FLT1FLT4
SCHEMBL3218635 0.79 GAA (0.45) KMT2AMEN1KCNA3FLT1FLT4
Propanil SCHEMBL3225616 0.78 KDM4E (0.54) KMT2AMEN1BCL2L1MCL1ALDH1A1
Bispyribac SCHEMBL3221711 0.78 KCNA3 (0.41) KCNA3RAB9AGPR119
SCHEMBL626675 0.78 KMT2A (0.48) KMT2AMEN1RAB9AALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100234227-A1 MICROEMULSION CONCENTRATES BAYER CROPSCIENCE AG (DE) 2010-09-16 US disclosed
US-20100048516-A1 PENETRATION ENHANCER FOR FUNGICIDES BAYER CROPSCIENCE AG (DE) 2010-02-25 US disclosed
US-20080176746-A1 avoids antagonistically reduced activity or overdosage otherwise requiring split applications; by employing an oil suspension concentrate BAYER CROPSCIENCE AG (DE) 2008-07-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100048516-A1 PENETRATION ENHANCER FOR FUNGICIDES DDT, DCPS, TYMP KMT2A 2677/4885MEN1 3463/4885KCNA3 1522/4885
US-20080176746-A1 avoids antagonistically reduced activity or overdosage otherwise requiring split applications; by employing an oil suspension concentrate LIPA, MGLL, ABHD6 KMT2A 2133/4885MEN1 2623/4885KCNA3 4830/4885
US-20100234227-A1 MICROEMULSION CONCENTRATES ADH1C, MGLL, ADH1A KMT2A 3486/4885MEN1 2548/4885KCNA3 3382/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.